Clinic
Methodist Hospitals of Dallas
Methodist Hospitals of Dallas was paid $3.20M by Medicaid between Aug 2020 and Dec 2024, across 64 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoMETHODIST HOSPITALS OF DALLAS
MANSFIELD, TX 76063
MANSFIELD, TX 76063
33aNPI1689629941assigned 05/24/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$3.20M
24GClaims92,921
24DCodes billed64
24AFirst – last monthAug 2020 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#102 of 320
Median peer was paid$205K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 821 | $29K | |
| 2021 | 18,971 | $495K | |
| 2022 | 30,184 | $1.06M | |
| 2023 | 29,280 | $1.22M | |
| 2024incomplete | 13,665 | $401K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 12,389 | 11,615 | $1.13M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 5,253 | 4,899 | $877K |
| 80053 | Comprehensive metabolic panel | 5.8% | 8,748 | 7,496 | $184K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.8% | 2,788 | 2,388 | $121K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.6% | 11,969 | 9,700 | $116K |
| 71045 | Radiologic examination, chest; single view | 3.5% | 4,591 | 4,231 | $113K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.2% | 2,657 | 2,566 | $104K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.9% | 3,384 | 3,074 | $92K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.1% | 436 | 416 | $66K |
| 41899 | Unlisted procedure, dentoalveolar structures | 1.8% | 70 | 67 | $56K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 732 | 694 | $45K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 701 | 649 | $40K |
52 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 670 | $31K |
| 99285 | Emergency room visit (most serious) | <1% | 419 | $30K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 214 | $21K |
| 84703 | <1% | 2,949 | $17K | |
| 81001 | <1% | 3,368 | $15K | |
| 83690 | <1% | 2,374 | $14K | |
| 83880 | <1% | 814 | $12K | |
| 84484 | <1% | 2,187 | $12K | |
| 87807 | <1% | 271 | $12K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 939 | $11K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,785 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,362 | $9K |
| 84702 | <1% | 611 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 287 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 140 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,055 | $5K |
| 87081 | <1% | 298 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 658 | $3K |
| 80069 | <1% | 105 | $3K | |
| G0378 | Hospital observation service, per hour | <1% | 38 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,028 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 313 | $2K |
| 85610 | <1% | 940 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,214 | $2K |
| 86850 | <1% | 154 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 28 | $1K |
| 85730 | <1% | 499 | $1K | |
| 86769 | <1% | 47 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,385 | $1K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 269 | $960.19 |
| 83735 | <1% | 339 | $929.24 | |
| 82550 | <1% | 317 | $922.22 | |
| 81003 | <1% | 524 | $907.31 | |
| 80076 | <1% | 28 | $708.98 | |
| 86901 | <1% | 437 | $690.96 | |
| 86900 | <1% | 437 | $690.88 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,123 | $558.89 |
| 83605 | <1% | 64 | $327.95 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,166 | $234.82 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 216 | $124.73 |
| 85379 | <1% | 40 | $120.75 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 39 | $117.72 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 38 | $115.27 |
| 84145 | <1% | 14 | $106.14 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 334 | $59.78 |
| 86140 | <1% | 14 | $33.18 | |
| 96376 | <1% | 26 | $8.56 | |
| 82962 | <1% | 1,790 | $4.92 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 13 | $0.75 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 691 | $0.27 |
| J3490 | Unclassified drugs | 0% | 65 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 67 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBJERKE, CRAIG (EXECUTIVE VP & CFO)
| Provider | Location | Paid |
|---|---|---|
| Methodist Hospitals of Dallas | Dallas, TX | $13.18M |
| Methodist Hospitals of Dallas | Dallas, TX | $12.59M |
| Methodist Hospitals of Dallas | Richardson, TX | $2.65M |
| Methodist Hospitals of Dallas | Midlothian, TX | $2.35M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.